- Home
- et cancer
- Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
4.9 (788) · $ 5.00 · In stock
Frontiers Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations
Cancers, Free Full-Text
Crafting a better T cell for immunotherapy
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
Pharmaceutics, Free Full-Text
Hutch News Fred Hutchinson Cancer Center
Current Oncology, Free Full-Text
Cancers, Free Full-Text
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
Frontiers Innate immunity in pancreatic cancer: Lineage tracing and function
Mice injected with IL-6 Pan02 have a survival advantage over mice
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Hutch News Fred Hutchinson Cancer Center
Cancers, Free Full-Text
Frontiers Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy
